New High Blood Pressure Guidelines

The wait is finally over: the high blood pressure guidelines that have been in the works for the past 3 years saw the light of day at the American Heart Association (AHA) 2017 Scientific Sessions.

 

nuevas-guias-de-hipertension

As expected, after the findings of the SPRINT trial and other recently published studies, the treatment goal was lowered and is now below 130/80 mm Hg.


Read also: FOURIER: Evolocumab Found Beneficial for Patients with Peripheral Vascular Disease of Prior MI”.


Blood pressure (BP) levels considered “prehypertension,” according to the Seventh Joint National Committee (JNC 7), are now an “elevated BP” category for patients with systolic 120 to 129 mm Hg and diastolic less than 80 mm Hg, and stage 1 hypertension for patients with systolic 130 to 139 mm Hg and diastolic 80 to 89 mm Hg. Patients with a systolic BP above 140 mm Hg and a diastolic BP above 90 mm Hg are now encompassed in stage 2 hypertension.

 

The consequence of this reclassification is that almost half of the population (45.6%) is now deemed to have hypertension vs. 31.9% according to JNC 7 criteria.


Read also: PRESERVE: IV Bicarbonate and Oral N-Acetylcysteine Do Not Prevent Contrast-Associated Acute Kidney Injury”.


This guideline has been published online before print in Hypertension and the Journal of the American College of Cardiology, and it is the culmination of a process that started in 2013 and comprised the review of over 1000 studies. The resulting document covers the prevention, detection, evaluation, and management of high blood pressure in adults.

 

There is an emphasis on the importance of lifestyle modification, beyond the levels of blood pressure and cardiovascular risk of patients.

 

Original title: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

Reference: Whelton PK et al. Hypertension. 2017; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...